MD+DI

06/04/2026

Medtronic did not come to play during its recent earnings report. The medtech titan delivered its strongest annual revenue growth in a decade.

The company cites Cardiac Ablation Solutions and Cardiac Rhythm Management segments as key drivers of the growth. You can read more below.

Medtronic reports $36.4B FY26 revenue, up 8.4%, with Q4 beating estimates by $200M. Cardiovascular segment leads with 78% cardiac ablation growth.

06/04/2026

Preparing for the EU AI Act: Essential Steps to Assess Your Impact

Wondering how to navigate the EU AI Act? Anne-Gabrielle HAIE from Steptoe LLP shares practical guidance on taking your first steps toward compliance.

Her insights focus on two critical areas:
*Assessing your organization's exposure – Understanding whether and how the regulation applies to your AI systems

*Determining risk classification – Identifying where your technology falls within the Act's risk-based framework

You can read more here: https://www.mddionline.com/artificial-intelligence/eu-ai-act-compliance-what-companies-need-to-know-about-penalties

06/02/2026

Could your medical device company be eligible for a tariff refund? In this clip from the latest Let's Talk Medtech episode, Wipfli's Cara Walton offers a detailed explanation of current tariff policies. Watch the full episode here: https://www.youtube.com/watch?v=srGtW9khIBU

05/07/2026

Amanda Pedersen's latest MD+DI article reveals how Medtronic is strategically positioning itself as a dominant force in neurosurgery through recent breakthrough achievements.

Curious about what's driving this transformation? Check out the full article to discover the key developments propelling Medtronic forward.

Following recent FDA clearances, Medtronic is accelerating access to its integrated planning, navigation, and robotics platform across Europe.

05/07/2026

Why Cybersecurity Is Now Essential for Medtech

In the past few months, Stryker, Intuitive, and Medtronic have all faced cyberattacks to some degree.

Medcrypt's Naomi Schwartz discusses these attacks and ways that medical device companies can take preventative measures against hackers in this all-new episode of Let's Talk Medtech.

Medtech giants face cyberattacks. MedCrypt's Naomi Schwartz shares how to defend against cyberattacks and comply with FDA guidelines.

04/27/2026

The iRhythm Technologies, Inc. Zio Monitor has undergone a remarkable transformation, now featuring a form factor that is 72% lighter and 55% smaller than its predecessor.

In this exclusive clip from Let’s Talk Medtech, iRhythm’s CFO Daniel Wilson dives into the details of this groundbreaking redesign, highlighting how the new form factor improves wearability and patient outcomes. You can watch the full episode here: https://bit.ly/4mX6TRZ

04/27/2026

It can sometimes be daunting for small medical device companies to implement strong quality management protocols. Mark Swanson, Partner at QRx Partners, discusses how startups and smaller companies can implement a quality management system in stages after his session at MD&M Trade Shows South.

04/27/2026

Steve McCartin, of Filmecc USA, Inc., discusses the major trends he's seeing in catheter design and development at MD&M Trade Shows South. https://bit.ly/4cQCiRq

04/27/2026

Logan McKnight, of GoodKnight Consulting, highlights key industry trends following her keynote at MD&M Trade Shows South. She emphasizes the growing impact of integration into workflows and the ongoing market consolidation as two of the most significant developments shaping the sector today.

04/27/2026

One of the biggest questions posed at . Should all AFib patients receive implantable loop recorders? Cardiologists debate the issue.

UCLA and North Texas cardiologists debate universal AFib monitoring at HRS 2026, with concerns over data overload vs. disease tracking needs.